Anti-factor H Autoantibody-Associated Hemolytic Uremic Syndrome: A Rare Entity in a Pediatric Patient
- PMID: 38910744
- PMCID: PMC11192440
- DOI: 10.7759/cureus.60872
Anti-factor H Autoantibody-Associated Hemolytic Uremic Syndrome: A Rare Entity in a Pediatric Patient
Abstract
An 11-year-old patient presented with the primary complaint of hematuria and vomiting. On further investigation and a series of diagnostic tests, including a biopsy and thrombotic microangiopathy (TMA) profile, the patient was diagnosed with thrombotic microangiopathy. TMA is a pathological process involving endothelial cell injury, leading to thrombocytopenia and microangiopathic hemolytic anemia. This case highlights the importance of considering TMA in pediatric patients presenting with nonspecific symptoms, such as loss of appetite. Further research is needed to understand the pathophysiology and optimal management strategies for pediatric TMA. This case adds to the growing body of literature on pediatric TMA and underscores the need for a high index of suspicion in similar clinical scenarios.
Keywords: ahus; anti-factor h antibody; atypical hemolytic uremic syndrome; complement mediated hus; thrombotic microangiopathies; thrombotic thrombocytopenic purpura.
Copyright © 2024, Singh et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


References
-
- Anti-compliment factor H antibody associated hemolytic uremic syndrome in children with abbreviated plasma exchanges: a 12-month follow-up study. Tiewsoh K, Govindarajan S, Dawman L, Rawat A, Ramachandran R, Hans R. https://pubmed.ncbi.nlm.nih.gov/34930853/ Iran J Kidney Dis. 2021;15:419–425. - PubMed
-
- Complement and the atypical hemolytic uremic syndrome in children. Loirat C, Noris M, Fremeaux-Bacchi V. https://doi.org/10.1007/s00467-008-0872-4. Pediatr Nephrol. 2008;23:1957–1972. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources